{"name":"Hansa Biopharma AB","slug":"hansa-biopharma-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Ides","genericName":"IMLIFIDASE","slug":"imlifidase","indication":"Renal transplant rejection","status":"marketed"},{"name":"Anti-CD20 antibodies","genericName":"Anti-CD20 antibodies","slug":"anti-cd20-antibodies","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Cyclophosphamide (CYC)","genericName":"Cyclophosphamide (CYC)","slug":"cyclophosphamide-cyc","indication":"Lymphomas (Hodgkin and non-Hodgkin)","status":"marketed"}]}],"pipeline":[{"name":"Ides","genericName":"IMLIFIDASE","slug":"imlifidase","phase":"marketed","mechanism":"Immunoglobulin gamma (IgG), heavy chain","indications":["Renal transplant rejection","Transplant of kidney"],"catalyst":""},{"name":"Anti-CD20 antibodies","genericName":"Anti-CD20 antibodies","slug":"anti-cd20-antibodies","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cyclophosphamide (CYC)","genericName":"Cyclophosphamide (CYC)","slug":"cyclophosphamide-cyc","phase":"marketed","mechanism":"Cyclophosphamide is an alkylating agent that cross-links DNA strands, preventing cell division and causing cell death in rapidly dividing cells.","indications":["Lymphomas (Hodgkin and non-Hodgkin)","Breast cancer","Ovarian cancer","Lung cancer","Leukemias"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-11-16","type":"pipeline","source":"simplywall.st","summary":"Hansa Biopharma AB (publ) (STO:HNSA) May Have Run Too Fast Too Soon With Recent 26% Price Plummet - simplywall.st","headline":"Hansa Biopharma AB (publ) (STO:HNSA) May Have Run Too Fast Too Soon With Recent 26% Price Plummet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBlcWg5QlR5dVJuOHhEY2hxZWhCTENzVHpYTkJRTG1yQ1NQNE5jbnVqTFVxOEpiQ2xoWXpWaG9mMVdIN2Qtc2h4a2xKY2VIUnczWGpYUjJ6R29ScHVfYzlvQW9xX3E2cHNfc2FJLWlDOGQ4UFlFaWJFQktvSU9QQQ?oc=5","date":"2025-07-30","type":"pipeline","source":"PharmaLive","summary":"Pharma people on the move: Summer 2025 roundup - PharmaLive","headline":"Pharma people on the move: Summer 2025 roundup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOWnNqWDRNaUxxcG1DT2FiVmJvZ3ZjZzBobXBsdjBWNEdkX3N0X1BIQ1dhMFdhNEVXQk92TEh4OEV0N2w4UjM1VW9OUWJGLXdkcVd4U2tleTlyTWxpVmxZMXRnQXE0dWZ0elAxZFpIamFfalU2MXlsWkpja0tyYzZ0Q29FZw?oc=5","date":"2025-07-29","type":"pipeline","source":"citybiz","summary":"Hansa Biopharma Expands Executive Team - citybiz","headline":"Hansa Biopharma Expands Executive Team","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPSjJNX3VaQnZGVWw5ZUswbTJCdVAxMWZrUEdqNXVsQnR0d3hKa1FPVFNmNWZhRnpOQTRRcVNaXzNIbkxyZG5ueDhfdnY4aTZHRjdmaWxXWnIyTGFpZW1FZVJmbXAzX1JoMG1BeENjYWRuc1ctb2dZSDFMeUY0WkYwdXcxdGoyeDVOdlJoUC0yd1pHN3lIX3c?oc=5","date":"2025-07-29","type":"pipeline","source":"Contract Pharma","summary":"Hansa Biopharma Makes Leadership Appointments - Contract Pharma","headline":"Hansa Biopharma Makes Leadership Appointments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQVEQtU2VJR3BfNkt4STV4WGVsRHB4bmJpNHlCZTN5RkRPak8tTm14UVZJS3FOcXplbXRmZEt6S1JVbTNrMGVaSDZUSHVCZzlwX21ycUxyT0QtLUJjYUJSZjZqeUtENzB3WGE1SHNNWWM5VGQ4bm9ONzhKZm5UQUhuT2Z2MjBvM0FCRGhpNUNJb3duOEE?oc=5","date":"2025-07-08","type":"pipeline","source":"Contract Pharma","summary":"Hansa Biopharma Names Chief Medical Officer - Contract Pharma","headline":"Hansa Biopharma Names Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPc1ZVdDJUV1BVQ1VTRGl3UURjMi1CNkRsSGFtZlQwMXpUaFBFWGxTd3ZXSEh0a1pEeTNxM3dBbjloNXc1TWxlMzJlNXBIYnZmdHh1MkhYb3ZDMHJUdDl0ZU91NHdsc19ZY0hoaWVaeUdYWDRFSXpLcjJORVFLODl6dGpJZmFsSl82?oc=5","date":"2025-05-27","type":"pipeline","source":"Contract Pharma","summary":"Hansa Biopharma Plans Restructuring - Contract Pharma","headline":"Hansa Biopharma Plans Restructuring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNZkN3alZmdnhHUUUwNXBuOElpRVdWX3V2aWUzWi1yYWQzTE00QldVRWZ5N2tndHVzczA4SWNZT18tNU84T2N2dE8tRU10N3d3MlhXTHFiNkdzX09PT1VmVEF2V1FnYnQ3R0d4MWJHMmRld0JzLTRLMVUxWVRRUnc3TEVuM0dOQjhW?oc=5","date":"2025-05-14","type":"pipeline","source":"BioCentury","summary":"Elevatebio names Ger Brophy interim CEO - BioCentury","headline":"Elevatebio names Ger Brophy interim CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPTUFhNTlNYndHNGhCU2tqNE5XTDJJYjhYVjgzU0EwcDR2Z3ZyRTZMQ280VEFOZEVSOEExeXh4RHZ2VkRkZEYxRzBTa281dHBhRFczYUhFQXhFLU1FS1RyOGowQ1ZQcnJhVGl2bkVaVERfdzJPVFE5MTFmV0lUdnA4cGh5ZlY?oc=5","date":"2025-04-24","type":"pipeline","source":"Contract Pharma","summary":"Hansa Biopharma Appoints New CEO - Contract Pharma","headline":"Hansa Biopharma Appoints New CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPbm4zOVhHSlhfajNGRXdqYzhfd3U5d2pXUThHVkdwUGozOHZGM2lCMktEOTFyTllRTVlSckM5ZTNaQU81TGhTdzkzcHZ0NzlLSGtfR3NaeXZrOFEydnR4dlFkUkF1TDNXUGpGQ2tlYUxlb1Z5Wlk3dE90N1otdkU1X3VaYXNtYjNM?oc=5","date":"2024-01-24","type":"pipeline","source":"marketscreener.com","summary":"Hansa Biopharma AB: Target Price Consensus and Analysts Recommendations | HNSA | SE0002148817 - marketscreener.com","headline":"Hansa Biopharma AB: Target Price Consensus and Analysts Recommendations | HNSA | SE0002148817","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBUOGZPRFhrWUE5N2JzQTZSNF9ITlM4Qi1CaWJhTms0MkdnXzFIdXhfR0VTQlczWDNxdXdxdG1Hd2NqNC03cEZPMkJFNE9XN1BJRTVtUVRSSzI4QkFo?oc=5","date":"2018-12-30","type":"pipeline","source":"TradingView","summary":"HNSA Stock Price and Chart — OMXSTO:HNSA - TradingView","headline":"HNSA Stock Price and Chart — OMXSTO:HNSA","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}